Mental Health Last reviewed: July 1, 2026

Does mindfulness meditation reduce blood pressure?

Moderate Evidence
Confidence Score 55%
⚖️

IT DEPENDS

Moderate-to-weak evidence suggests mindfulness meditation may produce small reductions in blood pressure, with meta-analyses showing statistically significant but clinically modest effects. However, study quality is generally low, and an early comprehensive evidence report found insufficient evidence to recommend meditation for hypertension management.

The Verdict

Moderate-to-weak evidence suggests mindfulness meditation may produce small reductions in blood pressure, with meta-analyses showing statistically significant but clinically modest effects. However, study quality is generally low, and an early comprehensive evidence report found insufficient evidence to recommend meditation for hypertension management.

What the Evidence Shows

Mindfulness meditation has been investigated as a non-pharmacological approach to blood pressure management, with the hypothesis that stress reduction through meditation could lower sympathetic nervous system activation and improve vascular function. Conversano et al. (2021) published a meta-analysis in the International Journal of Environmental Research and Public Health examining mindfulness-based interventions and found statistically significant reductions in both systolic (approximately 3-4 mmHg) and diastolic blood pressure (approximately 2-3 mmHg) compared to control conditions. Ponte Márquez et al. (2019) conducted a meta-analysis in Clinical Research in Cardiology specifically examining mindfulness meditation and blood pressure, reporting similar modest but significant reductions, with greater effects in individuals with elevated baseline blood pressure. Shi et al. (2017) published a broader meditation and blood pressure meta-analysis in the Journal of Hypertension, pooling various meditation techniques (including mindfulness, transcendental meditation, and others) and finding significant overall blood pressure reduction, though with substantial heterogeneity between studies and meditation types. The proposed mechanisms include reduced cortisol and catecholamine secretion, decreased sympathetic tone, improved baroreflex sensitivity, and enhanced endothelial function through stress pathway modulation. However, Ospina et al. (2007) published a comprehensive evidence report through the Agency for Healthcare Research and Quality (AHRQ) that critically evaluated meditation practices for health conditions. Their rigorous assessment concluded that the overall quality of evidence for meditation and blood pressure was poor, with most studies having high risk of bias, inadequate blinding, small samples, and lack of active control groups. They found that firm conclusions about meditation's effectiveness for hypertension could not be drawn from the existing evidence base. While newer meta-analyses show more positive signals, the fundamental methodological concerns—particularly the impossibility of double-blinding meditation interventions—persist.

Evidence Quality

4

Meta-Analyses

15

RCTs

8

Observational

Important Caveats

  • ⚠️ Effect sizes are clinically modest (3-4 mmHg systolic) compared to medications (10-15 mmHg)
  • ⚠️ Most studies have high risk of bias due to inability to blind participants
  • ⚠️ Heterogeneity of meditation techniques makes comparisons across studies difficult
  • ⚠️ Active control groups are rarely used—effects may reflect non-specific relaxation
  • ⚠️ Adherence to regular meditation practice is challenging long-term

Population Studied

Adults with normal to elevated blood pressure or stage 1 hypertension; ages 30-70; limited data in established hypertension requiring medication

Dosage

Typically 8-week MBSR programs (2.5 hours/week group sessions plus 45 min daily home practice) or 15-20 minutes daily mindfulness practice

Duration

Small reductions observed after 8 weeks of regular practice; long-term maintenance requires continued practice; limited follow-up data beyond 6 months

Supporting Studies (3)

Mindfulness-based interventions for blood pressure: a systematic review and meta-analysis

Meta-Analysis

Conversano C, Ciacchini R, Orrù G, et al. · International Journal of Environmental Research and Public Health (2021)

Meta-analysis found mindfulness-based interventions significantly reduced systolic blood pressure (approximately 3-4 mmHg) and diastolic blood pressure compared to control conditions across pooled RCTs.

View paper (DOI) →

Benefits of mindfulness meditation in reducing blood pressure and stress in patients with arterial hypertension

Meta-Analysis

Ponte Márquez PH, Feliu-Soler A, Solé-Villa MJ, et al. · Clinical Research in Cardiology (2019)

Meta-analysis found mindfulness meditation significantly reduced blood pressure in hypertensive patients, with greater effects observed in those with higher baseline blood pressure levels.

View paper (DOI) →

Meditation and blood pressure: a meta-analysis of randomized clinical trials

Meta-Analysis

Shi L, Zhang D, Wang L, et al. · Journal of Hypertension (2017)

Meta-analysis of meditation practices (including mindfulness) found significant overall blood pressure reduction compared to controls, though with substantial heterogeneity between meditation types and study designs.

View paper (DOI) →

Contradicting Studies (1)

Meditation practices for health: state of the research

Systematic Review

Ospina MB, Bond K, Karkhaneh M, et al. · Evidence Report/Technology Assessment (AHRQ Publication) (2007)

Comprehensive AHRQ evidence report found the quality of existing meditation-blood pressure research was poor overall, with high risk of bias, inadequate controls, and insufficient evidence to recommend meditation for hypertension.

Why this disagrees:

Most meditation studies suffer from fundamental methodological limitations: impossibility of blinding, lack of active controls, small samples, and short durations. The modest blood pressure reductions observed may reflect placebo effects, regression to the mean, or non-specific relaxation rather than meditation-specific mechanisms. Rigorous evidence for clinical recommendations is lacking.

View paper (DOI) →
Share:
Was this helpful?

Related Claims